The use of a second core needle biopsy to predict response to neoadjuvant chemotherapy in breast cancer patients, especially in the HER2-positive population
Early and accurate assessment of the response to neoadjuvant chemotherapy offers the potential to optimize treatment to obtain improved responses. We aimed to predict the response to neoadjuvant chemotherapy using a second breast core needle biopsy after a median of 2 cycles of neoadjuvant chemotherapy.
Source: Surgery - Category: Surgery Authors: Ying Zhang, Juping Shen, Siyu Wu, Ying Zhou, Zhimin Shao, Guangyu Liu Source Type: research
More News: Breast Cancer | Breast Needle Aspiration | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Surgery